5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.40%
Revenue growth similar to METSB.HE's 5.40%. Walter Schloss would see if both companies share industry tailwinds.
-35.41%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-61.56%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-61.56%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-168.70%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-168.65%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-168.65%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.13%
Share count expansion well above METSB.HE's 0.13%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.13%
Diluted share count expanding well above METSB.HE's 0.13%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-8.86%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-18.92%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
0.64%
Similar 10Y revenue/share CAGR to METSB.HE's 0.64%. Walter Schloss might see both firms benefiting from the same long-term demand.
9.32%
5Y revenue/share CAGR similar to METSB.HE's 9.32%. Walter Schloss might see both companies benefiting from the same mid-term trends.
-8.73%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-109.17%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-128.66%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-106.39%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-152.24%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-125.37%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-111.03%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
103.75%
10Y equity/share CAGR in line with METSB.HE's 103.75%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
39.08%
5Y equity/share CAGR is in line with METSB.HE's 39.08%. Walter Schloss would see parallel mid-term profitability and retention policies.
11.68%
3Y equity/share CAGR similar to METSB.HE's 11.68%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
193.55%
Similar 10Y dividend/share CAGR to METSB.HE's 193.55%. Walter Schloss expects both to share consistent earnings expansions and payout practices.
-11.88%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-4.37%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
14.48%
AR growth well above METSB.HE's 14.48%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.28%
Inventory growth well above METSB.HE's 1.28%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-1.36%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.26%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
8.90%
Debt growth far above METSB.HE's 8.90%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
9.92%
SG&A growth well above METSB.HE's 9.92%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.